Exceptional Vision and Execution

We have a successful history of executing and investing in biopharma companies with a focus on preclinical and early clinical-stage assets within CNS, inflammation, immunology, oncology and generics. We offer our partners access to our industry expertise, network of relationships, and active support in building their businesses over multi-year time horizons. Today, we maintain a portfolio of investments that span all stages from start-up to mature and publicly-traded.